Intrinsiqs

Is Caris Life Sciences, Inc. overvalued?

Caris Life Sciences, Inc. (CAI) — key valuation metrics and fundamentals.

No verdict
Price
$22.18
Fair value
Current P/E
Normal P/E
17.7
Market cap
$6.27B
Dividend yield
0.0%
Return on equity
18.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CAI's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.